Vice President, Pharmaceutical Development
Dr. Sesha Neervannan is currently Vice President of
Pharmaceutical Development at Allergan. In his current role, he
oversees the CMC activities related to developing the drug product
from discovery to commercialization that includes material
characterization, formulation, process engineering, device and
packaging engineering, analytical development and drug delivery
research and development efforts.
Prior to joining Allergan, he held senior positions at
Bristol-Myers Squibb and Amgen in both functional and team
leadership roles. He has several research publications and patents
and has been a recognized and invited speaker at several national
and international conferences. He serves on the several advisory
boards including the Scientific Advisory Board for “Cure for
Huntington Disease Initiative” (CHDI), a non-profit organization
dedicated to finding a cure for Huntington’s Disease, Customer
Advisory Board for NineSigma and the Editorial Advisory Board for
the journal Expert Opinion on Drug Delivery.
He earned his Ph.D. in Pharmaceutical Chemistry at the
University of Kansas.